Senior QA Technician
Zendal3w ago
Pontevedra
The English-language job board for Spain
89,000+ live jobsZendal
Grupo Zendal is a Spanish biotechnology and pharmaceutical group dedicated to research, development, manufacturing, and commercialization of biological products for human and animal health.
4 open
- Locations
- Pontevedra only
- Newest advert
- 23 days ago
- Work style
- All on-site
- Level
- Mid-Level for 3 of 4
- Locations
- Pontevedra only
- Newest advert
- 23 days ago
- Work style
- All on-site
- Level
- Mid-Level for 3 of 4
4 jobs
. Sorted by
Engineering Manager
Zendal1mo ago
Pontevedra
Technology Transfer Technician
Zendal1mo ago
Pontevedra
Regulatory Affairs Specialist - Human Health
Zendal2mo ago
Pontevedra
About the company
Grupo Zendal is a Spanish biotechnology and pharmaceutical group dedicated to research, development, manufacturing, and commercialization of biological products for human and animal health. With over 30 years of experience, the group comprises seven companies, including CZ Vaccines and Biofabri, and employs more than 650 people. It has been active in COVID-19 vaccine development and recently reported record sales of €133 million in 2025.
For International Professionals
- Headquartered in O Porriño, Pontevedra, Spain, offering a location in the Galicia region.
- Part of a group with multiple subsidiaries, potentially providing diverse roles across human and animal health.
- Involved in high-impact vaccine development, including COVID-19 and tuberculosis (MTBVAC) vaccines.
- Reported record sales of €133 million in 2025, indicating financial stability.
- International Zendal Awards since 2019 highlight a commitment to research and innovation.
Offices in Spain
Company History
Grupo Zendal is a Spanish biotechnology and pharmaceutical group founded in the 1990s, headquartered in O Porriño, Pontevedra, Spain. It comprises seven companies including CZ Vaccines, Biofabri, Vetia, Petia, Zinereo, Probisearch, and Zendal Portugal, focusing on research, development, manufacturing, and commercialization of products for human and animal health. The group has been involved in COVID-19 vaccine development and achieved record sales of €133 million in 2025.